South America Gastroparesis Market Forecast to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South America Gastroparesis Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South America Gastroparesis Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing prevelance of Diabetes Mellitus

5.2 Market Opportunities

5.2.1 Surging Clinical Trials

5.3 Future Trends

5.3.1 Technological Advancements and incresaing research on gastric stimulation

5.4 Impact of Drivers and Restraints

6. South America Gastroparesis Market Regional Analysis

6.1 South America Gastroparesis Market Overview

6.2 South America Gastroparesis Market Revenue 2018-2027 (US$ Million)

6.3 South America Gastroparesis Market Forecast Analysis

7. South America Gastroparesis Market Analysis – by Type

7.1 Idiopathic

7.1.1 Overview
7.1.2 Idiopathic: South America Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Diabetic

7.2.1 Overview
7.2.2 Diabetic: South America Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Post-Surgical

7.3.1 Overview
7.3.2 Post-Surgical: South America Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

8. South America Gastroparesis Market Analysis – by Drug Class

8.1 Prokinetic Agents

8.1.1 Overview
8.1.2 Prokinetic Agents: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Botulinum Toxin Injections

8.2.1 Overview
8.2.2 Botulinum Toxin Injections: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Antiemetic Agents

8.3.1 Overview
8.3.2 Antiemetic Agents: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9. South America Gastroparesis Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Antiemetic Agents: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Antiemetic Agents: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10. South America Gastroparesis Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South America Gastroparesis Market Breakdown, by Key Country, 2021 and 2027 (%)
10.1.1.1 South America Gastroparesis Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 Brazil: South America Gastroparesis Market Breakdown, by Type
10.1.1.1.2 Brazil: South America Gastroparesis Market Breakdown, by Drug Class
10.1.1.1.3 Brazil: South America Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.2 Argentina: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Argentina: South America Gastroparesis Market Breakdown, by Type
10.1.1.2.2 Argentina: South America Gastroparesis Market Breakdown, by Drug Class
10.1.1.2.3 Argentina: South America Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.3 Rest of South and Central America: South America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Rest of South and Central America: South America Gastroparesis Market Breakdown, by Type
10.1.1.3.2 Rest of South and Central America: South America Gastroparesis Market Breakdown, by Drug Class
10.1.1.3.3 Rest of South and Central America: South America Gastroparesis Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South America Gastroparesis Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Allergan Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ipca Laboratories Ltd.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Johnson and Johnson Services, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Pfizer Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights